1. Kobinger, W., Lillie, C., and Pichler, L. (1979a) N-allylderivative of Clonidine, a substance with specific bradycardic action at a cardiac site. Naunyn-Schmiedeberg’g Arch. Pharmacol.306, 255–262.
2. Kobinger, W., Lillie, C., and Pichler, L. (1979b) Cardiovascular action of N-allyl-clonidine (St 567), a substance with specific bradycardic action. Europ. J. Pharmacol.58, 141–150.
3. Traunecker, W. and Walland, A. (1980) Haemodynamic and Electrophysiologic Actions of Alinidine in the Dog. Arch. int. Pharmacodyn. Ther.224, 58–72.
4. Harron, D.W.G., Riddell, J.G., Shanks, R.G. (1981) Alinidine reduces heart-rate without blockade of betaadrenoceptors. The Lancet, Febr. 14, p. 351.
5. Kasper, W., Meinertz, T., Treese, N., Kersting, F., Pop. T., and Jähnchen, E. (1981) Clinical Electrophysiological Properties of N-Allyl-Clonidine (ST 567) in Man. J. Cardiovasc. Pharmacol.3, 39–47.